MAPT and prostate carcinoma: Additionally, MAPT (degree = 65) is correlated with microtubule assembly and stabilization (Weingarten et al., 1975), which can promote bicalutamide resistance and is associated with survival in prostate cancer (Sekino et al., 2020).